208 results on '"Deng, Guangtong"'
Search Results
2. Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
3. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
4. Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
5. Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
6. Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
7. Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
8. Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study
9. The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
10. Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling.
11. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
12. Convalescent plasma for patients with COVID-19
13. Prognostic value of liver biochemical parameters for COVID-19 mortality
14. The prevalence, complications, and risk factors for infantile hemangioma: a systematic review and meta‐analysis.
15. Association of inflammatory markers with the severity of COVID-19: A meta-analysis
16. Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study
17. Beclin 2 negatively regulates innate immune signaling and tumor development
18. The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
19. Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine
20. The causal relationship between alcohol consumption, smoking, coffee, tea intake and cutaneous melanoma: a two-sample Mendelian randomization study
21. Immunophenotyping characteristics and outcome of COVID‐19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir
22. Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
23. Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
24. A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients
25. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
26. Clinical determinants for fatality of 44,672 patients with COVID-19
27. Laparoscopic versus open gastrectomy for gastric cancer
28. Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report
29. Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
30. Real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized patients with COVID‐19: A retrospective cohort study
31. Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma
32. Cover Image, Volume 95, Number 2, February 2023
33. Two‐year impact of COVID‐19 pandemic on hospitalized patients with skin diseases in China
34. Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
35. Real-world effectiveness of Azvudine in hospitalized patients with COVID-19: a retrospective cohort study
36. Association of cutaneous melanoma with subsequent non-cutaneous malignancies - Who is at the Greatest Risk?
37. Serological response following COVID-19 vaccines in patients living with HIV: a dose-response meta- analysis
38. Back Cover Image, Volume 94, Number 12, December 2022
39. Clinical characteristics and outcomes of patients with COVID‐19 and psoriasis
40. The risk of developing second primary malignancies among colorectal cancer patients
41. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma
42. EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
43. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
44. Serological Response Following COVID-19 Vaccines in Patients Living with HIV: A Dose-Response Meta-Analysis
45. IRRS, an Immune-Cell-Pair-Based Prognosis Model for Cutaneous Melanoma
46. Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
47. Nomogram based on autophagy related genes for predicting the survival in melanoma
48. The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
49. Disulfidptosis: a new form of regulated cell death for cancer treatment.
50. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.